US Patent

US10080733 — Prodrugs of fumarates and their use in treating various diseases

Method of Use · Assigned to Alkermes Pharma Ireland Ltd · Expires 2033-09-20 · 7y remaining

Vulnerability score 45/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects compounds of formula (I) and their pharmaceutical compositions.

USPTO Abstract

The present invention provides compounds of formula (I), and pharmaceutical compositions thereof.

Drugs covered by this patent

Vumerity (DIROXIMEL FUMARATE) · Biogen

FDA Patent Use Codes

When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.

Code	Description	Drug
`U-1384`	—	Vumerity

Patent Metadata

Patent number: US10080733
Jurisdiction: US
Classification: Method of Use
Expires: 2033-09-20
Drug substance claim: Yes
Drug product claim: Yes
Assignee: Alkermes Pharma Ireland Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.